G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 102 filers reported holding G1 THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 6.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $296,000 | +16.1% | 11,200 | 0.0% | 0.11% | -9.3% |
| Q3 2019 | $255,000 | -94.3% | 11,200 | -92.3% | 0.12% | -92.9% |
| Q2 2019 | $4,472,000 | +174.2% | 146,000 | +48.3% | 1.66% | +175.0% |
| Q1 2019 | $1,631,000 | -43.4% | 98,482 | +36.8% | 0.60% | -56.0% |
| Q3 2018 | $2,884,000 | -7.6% | 72,000 | 0.0% | 1.37% | +14.4% |
| Q2 2018 | $3,121,000 | -18.1% | 72,000 | -30.1% | 1.20% | -19.4% |
| Q1 2018 | $3,813,000 | +393.3% | 103,000 | +164.1% | 1.49% | +444.7% |
| Q4 2017 | $773,000 | -20.4% | 39,000 | 0.0% | 0.27% | -27.8% |
| Q3 2017 | $971,000 | – | 39,000 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 98,482 | $1,631,000 | 0.60% |
| Opus Point Partners Management, LLC | 20,844 | $346,000 | 0.47% |
| HHLR ADVISORS, LTD. | 949,431 | $15,761,000 | 0.44% |
| Rhenman & Partners Asset Management AB | 212,169 | $3,522,000 | 0.41% |
| Virtus ETF Advisers LLC | 8,654 | $144,000 | 0.31% |
| BB BIOTECH AG | 671,925 | $11,154,000 | 0.28% |
| RA Capital Management | 363,051 | $6,027,000 | 0.26% |
| BDO Wealth Advisors, LLC | 35,234 | $585,000 | 0.17% |
| Birchview Capital, LP | 15,000 | $249,000 | 0.16% |
| SECOR Capital Advisors, LP | 37,205 | $618,000 | 0.13% |